As one would reasonably expect, key money managers have jumped into Acceleron Pharma Inc (NASDAQ:XLRN) headfirst. Benjamin A. Smith’s Laurion Capital Management assembled the most outsized position in Acceleron Pharma Inc (NASDAQ:XLRN), followed by Peter Kolchinsky’s RA Capital Management, which initiated a $11.5 million position during the quarter. The following funds were also among the new XLRN investors: Lei Zhang’s Hillhouse Capital Management, Jim Simons’s Renaissance Technologies, and Cliff Asness’s AQR Capital Management.
Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Acceleron Pharma Inc (NASDAQ:XLRN) but similarly valued. These stocks are The Buckle, Inc. (NYSE:BKE), Endurance International Group Hldgs Inc (NASDAQ:EIGI), Globalstar, Inc. (PINK:GSAT), and Methode Electronics Inc. (NYSE:MEI). This group of stocks’ market caps resemble XLRN’s market cap.
|Ticker||No of HFs with positions||Total Value of HF Positions (x1000)||Change in HF Position|
As you can see these stocks had an average of 14 hedge funds with bullish positions and the average amount invested in these stocks was $102 million. That figure was $158 million in XLRN’s case. Globalstar, Inc. (PINK:GSAT) is the most popular stock in this table. On the other hand Endurance International Group Hldgs Inc (NASDAQ:EIGI) is the least popular one with only 7 bullish hedge fund positions. Compared to these stocks Acceleron Pharma Inc (NASDAQ:XLRN) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.